Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors.
Nanographene oxide (NGO) is a novel nano-wall material that tracks to tumors in vivo, and which, as a consequence of its large surface area, has the capacity to carry a large payload. This study explores the use of anti-HER2 antibody (trastuzumab)-conjugated NGO, radiolabeled with (111)In-benzyl-die...
Main Authors: | Cornelissen, B, Able, S, Kersemans, B, Waghorn, P, Myhra, S, Jurkshat, K, Crossley, A, Vallis, K |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
Elsevier
2013
|
פריטים דומים
-
SPECT imaging and biodistribution studies of 111In-EGF-Au-PEG nanoparticles in vivo
מאת: Song, L, et al.
יצא לאור: (2016) -
Imaging DNA damage response (DDR) during oncogenesis
מאת: Cornelissen, B, et al.
יצא לאור: (2013) -
In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT.
מאת: Kersemans, V, et al.
יצא לאור: (2005) -
In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model.
מאת: Kersemans, V, et al.
יצא לאור: (2005) -
PET and SPECT imaging for the acceleration of anti-cancer drug development
מאת: Hillyar, C, et al.
יצא לאור: (2015)